HEADER TRANSLATION FACTOR/ANTIBIOTIC 04-OCT-11 3U2Q TITLE EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LFF571 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION FACTOR TU 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EF-TU 1, P-43; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THIOCILLIN GE2270 ANALOGUE NVP-LFF571; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: TUFA, B3339, JW3301; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS TRANSLATION FACTOR-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.J.PALESTRANT REVDAT 3 15-NOV-23 3U2Q 1 LINK ATOM REVDAT 2 13-SEP-23 3U2Q 1 REMARK SEQADV SEQRES HETSYN REVDAT 2 2 1 LINK REVDAT 1 02-MAY-12 3U2Q 0 JRNL AUTH M.J.LAMARCHE,J.A.LEEDS,A.AMARAL,J.T.BREWER,S.M.BUSHELL, JRNL AUTH 2 G.DENG,J.M.DEWHURST,J.DING,J.DZINK-FOX,G.GAMBER,A.JAIN, JRNL AUTH 3 K.LEE,L.LEE,T.LISTER,D.MCKENNEY,S.MULLIN,C.OSBORNE, JRNL AUTH 4 D.PALESTRANT,M.A.PATANE,E.M.RANN,M.SACHDEVA,J.SHAO, JRNL AUTH 5 S.TIAMFOOK,A.TRZASKO,L.WHITEHEAD,A.YIFRU,D.YU,W.YAN,Q.ZHU JRNL TITL DISCOVERY OF LFF571: AN INVESTIGATIONAL AGENT FOR JRNL TITL 2 CLOSTRIDIUM DIFFICILE INFECTION. JRNL REF J.MED.CHEM. V. 55 2376 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22315981 JRNL DOI 10.1021/JM201685H REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.315 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 582 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 11365 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3058 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3U2Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000068231. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.23 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11365 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1D8T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50MM TRIS PH8, 50MM NACL , PH 8.23, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 41.65150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.23650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.65150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.23650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 443 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 400 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 400 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 400 MODIFIED REMARK 400 REMARK 400 THE THIOCILLIN GE2270 ANALOGUE NVP-LFF571 IS THIOPEPTIDE, A MEMBER REMARK 400 OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: THIOCILLIN GE2270 ANALOGUE NVP-LFF571 REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 LYS A 2 REMARK 465 GLU A 3 REMARK 465 LYS A 4 REMARK 465 PHE A 5 REMARK 465 ARG A 58 REMARK 465 GLY A 59 REMARK 465 ILE A 60 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 7 -78.77 115.10 REMARK 500 PRO A 10 128.08 -36.88 REMARK 500 ASP A 21 39.67 35.36 REMARK 500 THR A 33 -81.43 -62.45 REMARK 500 LYS A 37 -79.03 -59.15 REMARK 500 PHE A 46 -74.47 -36.37 REMARK 500 ALA A 52 74.13 -117.30 REMARK 500 PRO A 53 -135.67 -72.14 REMARK 500 GLU A 54 -161.23 -20.21 REMARK 500 GLU A 55 -171.49 164.03 REMARK 500 LYS A 56 -103.24 177.77 REMARK 500 PRO A 111 109.96 -52.02 REMARK 500 VAL A 127 109.15 -46.93 REMARK 500 LEU A 134 99.13 -62.91 REMARK 500 CYS A 137 2.45 -68.50 REMARK 500 LEU A 146 3.73 -63.31 REMARK 500 PRO A 163 68.69 -59.03 REMARK 500 SER A 173 99.12 -160.58 REMARK 500 ALA A 174 1.22 -58.10 REMARK 500 LEU A 175 -62.22 -103.14 REMARK 500 ASP A 181 76.57 -63.16 REMARK 500 ALA A 182 -37.81 -35.62 REMARK 500 ALA A 205 -48.01 -21.44 REMARK 500 GLU A 215 -68.01 -106.64 REMARK 500 SER A 221 -62.95 -16.47 REMARK 500 ILE A 247 -58.03 58.78 REMARK 500 SER A 253 150.30 175.14 REMARK 500 ARG A 262 -7.42 86.64 REMARK 500 ALA A 270 130.86 -35.77 REMARK 500 PRO A 328 -166.88 -100.81 REMARK 500 ARG A 333 -71.33 51.53 REMARK 500 LYS A 390 116.53 -168.14 REMARK 500 MEN B 3 -167.62 -118.89 REMARK 500 VAL B 5 -50.94 -145.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 503 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 25 OG1 REMARK 620 2 HOH A 405 O 58.7 REMARK 620 3 HOH A 433 O 144.9 86.8 REMARK 620 4 GDP A 501 O2B 85.9 124.7 111.9 REMARK 620 5 GDP A 501 O2A 95.8 134.3 114.9 85.6 REMARK 620 6 GDP A 501 O1B 142.6 135.0 58.9 57.5 89.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF NVP-LFF571 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3U6K RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDK733 REMARK 900 RELATED ID: 3U6B RELATED DB: PDB REMARK 900 EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE GE2270A-LIKE ANTIBIOTIC COMPOUND IS REPRESENTED AS POLYMER. THE REMARK 999 FIRST 11 RESIDUES OF THE ANTIBIOTIC ARE IDENTICAL TO THE REMARK 999 CORRESPONDING RESIDUES IN GE2270A, WITH ONLY THE LAST RESIDUE REMARK 999 MODIFIED. DBREF 3U2Q A 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 3U2Q B 1 12 UNP Q7M0J8 THCL_PLARO 1 12 SEQADV 3U2Q MET A 0 UNP P0CE47 EXPRESSION TAG SEQADV 3U2Q ALA A 1 UNP P0CE47 EXPRESSION TAG SEQADV 3U2Q 7BB B 12 UNP Q7M0J8 CYS 12 SEE REMARK 999 SEQRES 1 A 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 A 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 A 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 A 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 A 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 A 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 A 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 A 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 A 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 A 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 A 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 A 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 A 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 A 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 A 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 A 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 A 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 A 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 A 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 A 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 A 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 A 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 A 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 A 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 A 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 A 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 A 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 A 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 A 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 A 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 A 394 LYS VAL LEU GLY SEQRES 1 B 12 SER BB9 MEN BB6 VAL BB7 GLY BB8 BB9 BB9 MH6 7BB MODRES 3U2Q BB9 B 2 CYS MODRES 3U2Q MEN B 3 ASN N-METHYL ASPARAGINE MODRES 3U2Q BB6 B 4 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 3U2Q BB7 B 6 CYS MODRES 3U2Q BB8 B 8 PHE (2S,3S)-BETA-HYDROXY-PHENYLALANINE MODRES 3U2Q BB9 B 9 CYS MODRES 3U2Q BB9 B 10 CYS MODRES 3U2Q MH6 B 11 SER 3-HYDROXY-2-IMINOPROPANOIC ACID HET BB9 B 2 6 HET MEN B 3 8 HET BB6 B 4 7 HET BB7 B 6 9 HET BB8 B 8 11 HET BB9 B 9 5 HET BB9 B 10 5 HET MH6 B 11 4 HET 7BB B 12 24 HET GDP A 501 28 HET MG A 503 1 HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM MEN N-METHYL ASPARAGINE HETNAM BB6 (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB7 (2Z)-2-AMINO-4-METHOXY-3-SULFANYLBUT-2-ENOIC ACID HETNAM BB8 (2S,3S)-BETA-HYDROXY-PHENYLALANINE HETNAM MH6 3-HYDROXY-2-IMINOPROPANOIC ACID HETNAM 7BB TRANS-4-({[(E)-1-AMINO-2-SULFANYLETHENYL](4- HETNAM 2 7BB CARBOXYBUTYL)CARBAMOYL}OXY)CYCLOHEXANECARBOXYLIC ACID HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM MG MAGNESIUM ION HETSYN BB8 BETA-HYDROXY-PHENYLALANINE; THREO-BETA-HYDROXY-L- HETSYN 2 BB8 PHENYLALANINE; (BETAS)-BETA-HYDROXY-L-PHENYLALANINE; HETSYN 3 BB8 L-THREO-3-PHENYLSERINE; L-THREO-BETA-PHENYLSERINE; 3- HETSYN 4 BB8 HYDROXY-L-PHENYLALANINE FORMUL 2 BB9 3(C3 H5 N O2 S) FORMUL 2 MEN C5 H10 N2 O3 FORMUL 2 BB6 C4 H7 N O2 S FORMUL 2 BB7 C5 H9 N O3 S FORMUL 2 BB8 C9 H11 N O3 FORMUL 2 MH6 C3 H5 N O3 FORMUL 2 7BB C15 H24 N2 O6 S FORMUL 3 GDP C10 H15 N5 O11 P2 FORMUL 4 MG MG 2+ FORMUL 5 HOH *89(H2 O) HELIX 1 1 GLY A 23 GLY A 40 1 18 HELIX 2 2 ALA A 45 ILE A 49 5 5 HELIX 3 3 GLY A 83 GLY A 94 1 12 HELIX 4 4 MET A 112 GLY A 126 1 15 HELIX 5 5 GLU A 147 TYR A 160 1 14 HELIX 6 6 LEU A 175 GLY A 180 1 6 HELIX 7 7 ASP A 181 ILE A 199 1 19 HELIX 8 8 ARG A 204 LYS A 208 5 5 HELIX 9 9 LYS A 282 ILE A 286 5 5 HELIX 10 10 SER A 312 GLY A 316 5 5 SHEET 1 A 6 SER A 65 THR A 71 0 SHEET 2 A 6 ARG A 74 ASP A 80 -1 O TYR A 76 N TYR A 69 SHEET 3 A 6 HIS A 11 ILE A 17 1 N VAL A 14 O ALA A 77 SHEET 4 A 6 ALA A 101 ALA A 106 1 O VAL A 104 N ILE A 17 SHEET 5 A 6 ILE A 130 ASN A 135 1 O ILE A 131 N ALA A 101 SHEET 6 A 6 ILE A 169 ARG A 171 1 O VAL A 170 N VAL A 132 SHEET 1 B 7 LEU A 211 PRO A 213 0 SHEET 2 B 7 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 B 7 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 B 7 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 B 7 ASN A 273 ARG A 279 -1 O LEU A 277 N THR A 256 SHEET 6 B 7 GLY A 224 ARG A 230 -1 N THR A 225 O LEU A 278 SHEET 7 B 7 VAL A 217 ILE A 220 -1 N ILE A 220 O GLY A 224 SHEET 1 C 5 LEU A 211 PRO A 213 0 SHEET 2 C 5 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 C 5 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 C 5 GLN A 251 MET A 260 -1 O SER A 253 N VAL A 242 SHEET 5 C 5 LYS A 263 LEU A 265 -1 O LEU A 265 N VAL A 258 SHEET 1 D 2 ILE A 235 LYS A 237 0 SHEET 2 D 2 GLU A 267 ARG A 269 -1 O GLY A 268 N ILE A 236 SHEET 1 E 7 LYS A 299 ILE A 310 0 SHEET 2 E 7 ASN A 355 MET A 368 -1 O MET A 358 N SER A 306 SHEET 3 E 7 THR A 335 GLU A 342 -1 N THR A 338 O ILE A 363 SHEET 4 E 7 GLN A 329 PHE A 332 -1 N PHE A 330 O VAL A 337 SHEET 5 E 7 ARG A 373 GLU A 378 -1 O ALA A 375 N TYR A 331 SHEET 6 E 7 ARG A 381 VAL A 391 -1 O GLY A 384 N ILE A 376 SHEET 7 E 7 LYS A 299 ILE A 310 -1 N TYR A 309 O ALA A 385 SHEET 1 F 2 PHE A 322 PHE A 323 0 SHEET 2 F 2 MET A 349 VAL A 350 -1 O VAL A 350 N PHE A 322 LINK C SER B 1 N BB9 B 2 1555 1555 1.33 LINK C SER B 1 SG BB9 B 2 1555 1555 1.72 LINK CA SER B 1 C BB9 B 10 1555 1555 1.44 LINK CB SER B 1 CB MH6 B 11 1555 1555 1.43 LINK C BB9 B 2 N MEN B 3 1555 1555 1.32 LINK C MEN B 3 SG BB6 B 4 1555 1555 1.74 LINK C MEN B 3 N BB6 B 4 1555 1555 1.34 LINK C BB6 B 4 N VAL B 5 1555 1555 1.38 LINK C VAL B 5 SG BB7 B 6 1555 1555 1.79 LINK C VAL B 5 N BB7 B 6 1555 1555 1.33 LINK C BB7 B 6 N GLY B 7 1555 1555 1.34 LINK C GLY B 7 N BB8 B 8 1555 1555 1.30 LINK C BB8 B 8 N BB9 B 9 1555 1555 1.31 LINK C BB8 B 8 SG BB9 B 9 1555 1555 1.78 LINK C BB9 B 9 N BB9 B 10 1555 1555 1.32 LINK C BB9 B 9 SG BB9 B 10 1555 1555 1.74 LINK C BB9 B 10 N MH6 B 11 1555 1555 1.33 LINK C MH6 B 11 SG 7BB B 12 1555 1555 1.76 LINK C MH6 B 11 N 7BB B 12 1555 1555 1.31 LINK OG1 THR A 25 MG MG A 503 1555 1555 2.49 LINK O HOH A 405 MG MG A 503 1555 1555 2.57 LINK O HOH A 433 MG MG A 503 1555 1555 2.43 LINK O2B GDP A 501 MG MG A 503 1555 1555 2.51 LINK O2A GDP A 501 MG MG A 503 1555 1555 2.71 LINK O1B GDP A 501 MG MG A 503 1555 1555 2.72 SITE 1 AC1 18 HIS A 19 VAL A 20 ASP A 21 HIS A 22 SITE 2 AC1 18 GLY A 23 LYS A 24 THR A 25 THR A 26 SITE 3 AC1 18 PHE A 46 ASP A 50 ASN A 135 LYS A 136 SITE 4 AC1 18 ASP A 138 MET A 139 SER A 173 LEU A 175 SITE 5 AC1 18 HOH A 433 MG A 503 SITE 1 AC2 5 THR A 25 ASP A 50 HOH A 405 HOH A 433 SITE 2 AC2 5 GDP A 501 SITE 1 AC3 25 THR A 38 TYR A 39 PRO A 72 GLU A 215 SITE 2 AC3 25 ASP A 216 PHE A 218 THR A 228 THR A 256 SITE 3 AC3 25 GLY A 257 GLU A 259 PHE A 261 ARG A 262 SITE 4 AC3 25 ASN A 273 VAL A 274 GLY A 275 LEU A 277 SITE 5 AC3 25 LYS A 303 HIS A 319 THR A 320 PRO A 321 SITE 6 AC3 25 PHE A 323 HOH A 407 HOH B 13 HOH B 18 SITE 7 AC3 25 HOH B 87 CRYST1 83.303 132.473 37.433 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012004 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007549 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026714 0.00000